Is a complete ETR/5CV research report available?

Question

Accepted Answer

No complete published report is available for etr/5CV (ETR/5CV) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Revenue (ttm)	70.7M
Net income (ttm)	128.8M
EPS (ttm)	€0.80
Volume	125,272
Beta	1.87

Metric	Value
Country	Netherlands
Country code	DE
Employees	983
Employees Change	-189%
Employees Change Percent	-16.13
Exchange	Deutsche Börse Xetra
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Isin	NL0015436031
Last refreshed	2026-09-12
Price	EUR 3.91
Price currency	EUR
Sector	Healthcare
Sector PE	37.53
Sector PE Fwd	14.15
Sic	2836
Symbol	etr/5CV

Metric	Value
EBIT Margin	257.38%
EBITDA Margin	273.81%
Gross margin	93.29%
Gross Profit	EUR 66M
Gross Profit Growth	-83.23%
Gross Profit Growth Q	-88.61%
Gross Profit Growth5 Y	14.42%
Net Income	EUR 128.8M
Net Income Growth	18.96%
Net Income Growth Q	-19.17%
Net Income Growth Years	1%
Pretax Margin	222.5%
Profit Margin	182.11%
Profitable Quarters	EUR 1
Profitable Years	1
Roa5y	-15.2
ROCE	20.18
Roe5y	-32.21
ROIC	41.4

Metric	Value
Cagr1y	13.29%
Cagr3y	-13.74%
Cagr5y	-43.7%
EPS Growth	94.02
EPS Growth Q	23.97
EPS Growth Years	3
FCF Growth Q	-91.56%
OCF Growth Q	-91.57%
Revenue Growth	-86.98x
Revenue Growth Q	-89.04x
Revenue Growth Qo Q	4,248.11x
Revenue Growth Years	1x
Revenue Growth3 Y	-9.97x
Revenue Growth5 Y	7.34x

Metric	Value
Assets	EUR 1.1B
Cash	EUR 416.1M
Current Assets	EUR 873.1M
Current Liabilities	EUR 236.2M
Debt	EUR 35.1M
Debt EBITDA	EUR 0.18
Debt Equity	EUR 0.04
Debt FCF	EUR -0.28
Equity	EUR 871.2M
Interest Coverage	29.46
Liabilities	EUR 267.4M
Long Term Assets	EUR 265.5M
Long Term Liabilities	EUR 31.2M
Net Cash	EUR 381M
Net Debt EBITDA	EUR -1.97
Net Debt Equity	EUR -0.44
Tangible Book Value	EUR 846.6M
Tangible Book Value Per Share	EUR 4.68

ETR/5CV (ETR/5CV)

Price

Financial snapshot

Fair-value bridge

Latest news · ETR/5CV

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ETR/5CV indicators

Profile and market data

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on ETR/5CV

Frequently asked questions

Metric	Value
Current ratio	3.7
Net Working Capital	EUR 225.6M
Quick ratio	1.88
Working Capital	EUR 636.9M

Metric	Value
1Y total return	13.28%
200-day SMA	4.14
3Y total return	-35.82%
50-day SMA	4.35
50-day SMA vs 200-day SMA	50over200
5Y total return	-94.34%
All Time High	120.8
All Time High Change	-96.77%
All Time High Date	2020-12-09
All Time Low	2
All Time Low Change	95.3%
All Time Low Date	2025-04-07
ATR	0.17
Beta	1.87
Ch YTD	7.9
High	3.96
High52	4.9
High52 Date	2025-06-12
High52ch	-20.29%
Low	3.86
Low52	2
Low52 Date	2025-04-07
Low52ch	95.3%
Ma50ch	-10.29%
Price vs 200-day SMA	-5.7%
RSI	43.6
RSI Monthly	41.93
RSI Weekly	41.84
Sharpe ratio	0.17x
Sharpe Ratio3y	-0.23x
Sharpe Ratio5y	-0.51x
Sortino ratio	0.43
Sortino Ratio3y	-0.26
Sortino Ratio5y	-0.64
Total Return	38.7%
Tr YTD	7.9
Tr1m	-11.43%
Tr1w	8.02%
Tr3m	-15.31%

Metric	Value
Adjusted FCF	EUR -129.6M
Adjusted OCF	-125,599,000
Average Volume	427,092.45x
Bv Per Share	4.81
CAPEX	EUR -4M
Ch1m	-11.43
Ch1w	8.02
Ch1y	13.28
Ch3m	-15.31
Ch3y	-35.82
Ch5y	-94.34
Ch6m	-14.79
Change	0.72%
Change From Open	0.26
Close	3.88
Days Gap	0.46
Depreciation Amortization	11,618,000
Dollar Volume	489,312.4
Earnings Date	2026-04-24
EBIT	EUR 182.1M
EBITDA	EUR 193.7M
EPS	EUR 0.8
F Score	2
FCF	EUR -124.1M
Financing CF	-5,189,000
Fiscal Year End	December
Founded	2,000
Graham Number	9.29886
Graham Upside	138.1
Income Tax	EUR 28.6M
Investing CF	-4,958,000
Is Primary Listing	0
Last Earnings Date	2025-11-12
Last Report Date	2025-09-30
Ma150	4.51
Ma150ch	-13.35%
Ma20	4.02
Ma20ch	-2.81%
Net CF	-134,772,000
Open	3.9
Position In Range	44.9
Ppne	235,603,000
Price Date	2026-01-05
Relative Volume	0.29x
Revenue	70,741,000x
SBC By Revenue	7.72x
Share Based Comp	5,462,000
Tax By Revenue	40.39x
Tax Rate	18.15%
Tr6m	-14.79%
Volume	125,272
Z Score	1.52

Metric	Value
Net Borrowing	-5,249,000
Shares Qo Q	-21.6%
Shares Yo Y	-38.7%